AstraZeneca said it is on track to hit its revenue target for 2030 and has drugs in the pipeline to fuel growth beyond, as the company reported higher second-quarter sales driven by its cancer ...

June inflation and employment data strengthened the case for the Federal Reserve to leave rates unchanged at its July meeting even as a renewed jump in oil prices threatens to reignite upward price ...

'I have an IRA, a high-yield savings account, four CDs and checking and savings accounts' "My first thought was simply to put it into another CD, especially since my current CDs are earning close to 4 ...

Argenx said it reached an agreement to buy Forte Biosciences for $2.2 billion, moving to strengthen its immunology pipeline. European pharmaceutical company Argenx is acquiring Nasdaq-listed Forte for ...

Provided by PR Newswire Jul 26, 2026, 2:08:00 PM ...

Rising Treasury yields show how 'enormously worried' the market is about inflation - and whether the Fed will back up its tough talk with action Federal Reserve Chair Kevin Warsh may need to raise ...

American Express AXP reported solid second-quarter earnings as higher spending on its cards drove strong revenue growth. Net revenue increased 10% from last year to $19.6 billion while diluted ...

Medtronic's standing as the largest pure-play medical-device maker remains a force to be reckoned with in the medical technology landscape. Medtronic's diversified product portfolio aimed at a wide ...

This High-Quality Stock Is on Sale; Should You Buy the Dip?

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details.

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.